A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation - PubMed (original) (raw)
A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation
D Beckett et al. Protein Sci. 1999 Apr.
Abstract
The Escherichia coli biotin holoenzyme synthetase, BirA, catalyzes transfer of biotin to the epsilon amino group of a specific lysine residue of the biotin carboxyl carrier protein (BCCP) subunit of acetyl-CoA carboxylase. Sequences of naturally biotinylated substrates are highly conserved across evolutionary boundaries, and cross-species biotinylation has been demonstrated in several systems. To define the minimal substrate requirements in BirA-catalyzed biotinylation, we have measured the kinetics of modification of a 23-residue peptide previously identified by combinatorial methods. Although the sequence of the peptide bears little resemblance to the biotinylated sequence in BCCP, it is enzymatically biotinylated in vivo. Rates of biotin transfer to the 23-residue peptide are similar to those determined for BCCP. To further elucidate the sequence requirements for biotinylation, transient kinetic measurements were performed on a series of amino- and carboxy-terminal truncations of the 23-mer. The results, determined by stopped-flow fluorescence, allowed identification of a 14-residue peptide as the minimum required sequence. Additional support was obtained using matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometric analysis of peptides that had been incubated with an excess of biotinyl-5'-adenylate intermediate and catalytic amounts of BirA. Results of these measurements indicate that while kinetically inactive truncations showed no significant shift in molecular mass to the values expected for biotinylated species, kinetically active truncations exhibited 100% biotinylation. The specificity constant (k(cat)/Km) governing BirA-catalyzed biotinylation of the 14-mer minimal substrate is similar to that determined for the natural substrate, BCCP. We conclude that the 14-mer peptide efficiently mimics the biotin acceptor function of the much larger protein domain normally recognized by BirA.
Similar articles
- The C-terminal domain of biotin protein ligase from E. coli is required for catalytic activity.
Chapman-Smith A, Mulhern TD, Whelan F, Cronan JE Jr, Wallace JC. Chapman-Smith A, et al. Protein Sci. 2001 Dec;10(12):2608-17. doi: 10.1110/ps.22401. Protein Sci. 2001. PMID: 11714929 Free PMC article. - A plasmid expression system for quantitative in vivo biotinylation of thioredoxin fusion proteins in Escherichia coli.
Smith PA, Tripp BC, DiBlasio-Smith EA, Lu Z, LaVallie ER, McCoy JM. Smith PA, et al. Nucleic Acids Res. 1998 Mar 15;26(6):1414-20. doi: 10.1093/nar/26.6.1414. Nucleic Acids Res. 1998. PMID: 9490786 Free PMC article. - Comparison of the backbone dynamics of the apo- and holo-carboxy-terminal domain of the biotin carboxyl carrier subunit of Escherichia coli acetyl-CoA carboxylase.
Yao X, Soden C Jr, Summers MF, Beckett D. Yao X, et al. Protein Sci. 1999 Feb;8(2):307-17. doi: 10.1110/ps.8.2.307. Protein Sci. 1999. PMID: 10048324 Free PMC article. - The enzymatic biotinylation of proteins: a post-translational modification of exceptional specificity.
Chapman-Smith A, Cronan JE Jr. Chapman-Smith A, et al. Trends Biochem Sci. 1999 Sep;24(9):359-63. doi: 10.1016/s0968-0004(99)01438-3. Trends Biochem Sci. 1999. PMID: 10470036 Review. - Molecular biology of biotin attachment to proteins.
Chapman-Smith A, Cronan JE Jr. Chapman-Smith A, et al. J Nutr. 1999 Feb;129(2S Suppl):477S-484S. doi: 10.1093/jn/129.2.477S. J Nutr. 1999. PMID: 10064313 Review.
Cited by
- Repurposing Proximity-Dependent Protein Labeling (BioID2) for Protein Interaction Mapping in E. coli.
Killelea T, Kemm FE, He L, Rudolph CJ, Bolt EL. Killelea T, et al. Methods Mol Biol. 2024;2828:87-106. doi: 10.1007/978-1-0716-4023-4_9. Methods Mol Biol. 2024. PMID: 39147973 - A ubiquitin-specific, proximity-based labeling approach for the identification of ubiquitin ligase substrates.
Mukhopadhyay U, Levantovsky S, Carusone TM, Gharbi S, Stein F, Behrends C, Bhogaraju S. Mukhopadhyay U, et al. Sci Adv. 2024 Aug 9;10(32):eadp3000. doi: 10.1126/sciadv.adp3000. Epub 2024 Aug 9. Sci Adv. 2024. PMID: 39121224 Free PMC article. - Engineered reversible inhibition of SpyCatcher reactivity enables rapid generation of bispecific antibodies.
Hentrich C, Putyrski M, Hanuschka H, Preis W, Kellmann SJ, Wich M, Cavada M, Hanselka S, Lelyveld VS, Ylera F. Hentrich C, et al. Nat Commun. 2024 Jul 15;15(1):5939. doi: 10.1038/s41467-024-50296-y. Nat Commun. 2024. PMID: 39009599 Free PMC article. - Engineering a SARS-CoV-2 vaccine targeting the RBD cryptic-face via immunofocusing.
Bruun TUJ, Do J, Weidenbacher PA, Kim PS. Bruun TUJ, et al. bioRxiv [Preprint]. 2024 Jun 5:2024.06.05.597541. doi: 10.1101/2024.06.05.597541. bioRxiv. 2024. PMID: 38895327 Free PMC article. Preprint. - AviTrap: A novel solution to achieve complete biotinylation.
Lu C, Bevers J, Tyagi T, To H, Lin M, Ti S, Nakamura G, Lin W, Chen Y, Wu Y, Li H, Wu J, Wang F. Lu C, et al. PLoS One. 2024 Apr 25;19(4):e0297122. doi: 10.1371/journal.pone.0297122. eCollection 2024. PLoS One. 2024. PMID: 38662671 Free PMC article.
References
- Gene. 1996 Feb 22;169(1):59-64 - PubMed
- Proc Natl Acad Sci U S A. 1995 May 9;92(10):4626-30 - PubMed
- J Biol Chem. 1996 Aug 23;271(34):20690-8 - PubMed
- Structure. 1995 Dec 15;3(12):1407-19 - PubMed
- Science. 1996 Oct 4;274(5284):94-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous